← Leaderboards
David William Scott
American National Red Cross
$13,836,753
Attributed
$14,777,618
Total exposure
16
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $945.7K · FY2005–23$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$14,777,618 · 16
By mechanism
R01$11,723,409 · 5
R21$2,310,667 · 5
R56$379,781 · 1
P01$187,228 · 1
T32$95,553 · 1
R25$60,480 · 1
Top collaborators
- Kathleen Palmer Pratt4 shared
- John E Weldon2 shared
Most similar at American National Red Cross
Same institution · by research overlap
- Robert G. Hawley$4,907,225
- Marco Melo$181,431
- Dorothea H Scandella$271,250
Others in their field
Top investigators on “Chimeric Proteins”
- David Heimbrook · Leidos Biomedical Research, Inc.$56,453,265
- Mohamed H Sayegh · University Of Pennsylvania$26,754,200
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$26,234,170
- Robert A Wood · Johns Hopkins University$24,963,233
- Larry Arthur$22,516,306
- Anne Moscona · Mount Sinai School Of Medicine Of Nyu$17,953,641
Research focus
Chimeric ProteinsGene TherapyB-LymphocytesIn VivoPreventT-LymphocyteImmune ResponseCytokineBaseFutureEpitopesImmunoglobulin GIn VitroCellsTranslatingAntigensResponseHemophilia AEngineeringAntibody FormationLeadRegulatory T-LymphocyteIl2ra GeneProduction
Grant awards (58)
Bispecific antibody to target FVIII-specific B cells$182,625
R21 · FY2023 · HL · contact PI
Induction of tolerance to FVIII by engineered T regulatory cells in hemophilia$369,989
R01 · FY2022 · HL · contact PI
Bispecific antibody to target FVIII-specific B cells$219,150
R21 · FY2022 · HL · contact PI
Induction of tolerance to FVIII by engineered T regulatory cells in hemophilia$369,989
R01 · FY2021 · HL · contact PI
Engineering Specific Regulatory T Cells to Treat Allergy$190,621
R21 · FY2021 · AI · contact PI
Induction of tolerance to FVIII by engineered T regulatory cells in hemophilia$369,989
R01 · FY2020 · HL · contact PI
Engineering Specific Regulatory T Cells to Treat Allergy$228,744
R21 · FY2020 · AI · contact PI
Induction of tolerance to FVIII by engineered T regulatory cells in hemophilia$369,989
R01 · FY2019 · HL · contact PI
Induction of Tolerance to FVIII in Hemophilia$389,467
R01 · FY2018 · HL · contact PI
Induction of Tolerance to FVIII in Hemophilia$473,337
R01 · FY2017 · HL · contact PI
Engineered CARs Targeting FVIII-specific T and B Cells$192,821
R21 · FY2017 · HL · contact PI
Induction of Tolerance to FVIII in Hemophilia$389,467
R01 · FY2016 · HL · contact PI
Engineered CARs Targeting FVIII-specific T and B Cells$231,385
R21 · FY2016 · HL · contact PI
Anitgen specific human T regulatory cell suppression of CCR6 positive Th17 cells$83,870
R01 · FY2016 · HL · contact PI
Induction of Tolerance to FVIII in Hemophilia$389,467
R01 · FY2015 · HL · contact PI
Mechanisms of Tolerance Induction to FVIII in Hemophilia$379,781
R56 · FY2014 · HL · contact PI
Gene Therapeutic Approach for Tolerance Induction$352,396
R01 · FY2013 · AI · contact PI
Induction of Tolerance to Factor VIII in Hemophilia$378,675
R01 · FY2012 · HL · contact PI
Gene Therapeutic Approach for Tolerance Induction$374,888
R01 · FY2012 · AI · contact PI
Induction of Tolerance to Factor VIII in Hemophilia$382,500
R01 · FY2011 · HL · contact PI
Gene Therapeutic Approach for Tolerance Induction$374,888
R01 · FY2011 · AI · contact PI
Induction of Tolerance to Factor VIII in Hemophilia$369,605
R01 · FY2010 · HL · contact PI
Gene Therapeutic Approach for Tolerance Induction$252,860
R01 · FY2010 · AI · contact PI
Gene Therapeutic Approach for Tolerance Induction$118,390
R01 · FY2010 · AI · contact PI
Induction of Tolerance to Factor VIII in Hemophilia$12,642
R01 · FY2010 · HL · contact PI
Induction of Tolerance to Factor VIII in Hemophilia$375,000
R01 · FY2009 · HL · contact PI
Gene Therapeutic Approach for Tolerance Induction$375,000
R01 · FY2009 · AI · contact PI
Gene Therapeutic Approach for Tolerance Induction$66,823
R01 · FY2009 · AI · contact PI
Induction of Tolerance to Factor VIII in Hemophilia$375,000
R01 · FY2008 · HL · contact PI
Mechanism of B-cell Delivered Tolerance in Diabetes$311,976
R01 · FY2008 · DK · contact PI
Mechanism of B-cell Delivered Tolerance in Diabetes$311,127
R01 · FY2007 · DK · contact PI
Induction of Tolerance to Factor VIII in Hemophilic$326,274
R01 · FY2006 · HL · contact PI
Mechanism of B-cell Delivered Tolerance in Diabetes$311,850
R01 · FY2006 · DK · contact PI
Gene Therapeutic Approach for Tolerance Induction$307,621
R01 · FY2006 · AI · contact PI
Induction of Tolerance to Factor VIII in Hemophilic$334,125
R01 · FY2005 · HL
Gene Therapeutic Approach for Tolerance Induction$307,870
R01 · FY2005 · AI
Novel Methods for B-cell Delivery of Tolerogenic Epitop*$187,500
R21 · FY2005 · DK
Induction of Tolerance to Factor VIII in Hemophilic$334,125
R01 · FY2004 · HL
Gene Therapeutic Approach for Tolerance Induction$300,925
R01 · FY2004 · AI
Novel Methods for B-cell Delivery of Tolerogenic Epitop*$184,850
R21 · FY2004 · DK
Gene Therapeutic Approach for Tolerance Induction$308,400
R01 · FY2003 · AI
Induction of Tolerance to Factor VIII in Hemophilic$296,000
R01 · FY2003 · HL
Designing IgG Constructs for Tolerance to Diabetogenic *$175,199
R21 · FY2003 · DK
Designing IgG Constructs for Tolerance to Diabetogenic *$55,172
R21 · FY2003 · DK
Mechanisms of Immunologic Tolerance and Its Breakdown$15,500
R13 · FY2003 · AI
Gene Therapeutic Approach for Tolerance Induction$308,400
R01 · FY2002 · AI
Designing IgG Constructs for Tolerance to Diabetogenic *$231,300
R21 · FY2002 · DK
INDUCTION OF TOLERANCE--FACTOR VIII IN HEMOPHILIC MICE$271,250
R01 · FY2001 · HL
Designing IgG Constructs for Tolerance to Diabetogenic *$231,300
R21 · FY2001 · DK
REGULATION OF B LYMPHOMA GROWTH AND APOPTOSIS$76,973
R01 · FY2001 · CA
REGULATION OF B LYMPHOMA GROWTH AND APOPTOSIS$290,979
R01 · FY2000 · CA
GENE THERAPEUTIC APPROACH FOR TOLERANCE INDUCTION$232,907
R01 · FY2000 · AI
CORE--IMMUNOLOGY FACILITY$187,228
P01 · FY2000 · HL
TRANSFUSION MEDICINE RESEARCH TRAINING PROGRAM$95,553
T32 · FY2000 · HL
REGULATION OF B LYMPHOMA GROWTH AND APOPTOSIS$76,973
R01 · FY2000 · CA
TEACHING BIOLOGY THROUGH IMMUNOLOGY FELLOWSHIPS$60,480
R25 · FY2000 · AI
MECHANISMS OF IMMUNOLOGIC TOLERANCE AND ITS BREAKDOWN$5,000
R13 · FY2000 · AI
GENE THERAPEUTIC APPROACH FOR TOLERANCE INDUCTION$1,403
R01 · FY2000 · AI